Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.

Guo X, Yang M, Gu H, Zhao J, Zou L.

Cancer Epidemiol. 2013 Oct;37(5):732-6. doi: 10.1016/j.canep.2013.05.002. Epub 2013 Jun 1.

PMID:
23731550
2.

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J.

Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.

3.

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.

Guo X, Xiong L, Zou L, Sun T, Zhang J, Li H, Peng R, Zhao J.

Diagn Pathol. 2012 Aug 13;7:96. doi: 10.1186/1746-1596-7-96.

4.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

5.

NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.

Aigelsreiter A, Haybaeck J, Schauer S, Kiesslich T, Bettermann K, Griessbacher A, Stojakovic T, Bauernhofer T, Samonigg H, Kornprat P, Lackner C, Pichler M.

Hum Pathol. 2012 Jul;43(7):1012-9. doi: 10.1016/j.humpath.2011.08.009. Epub 2011 Dec 15.

PMID:
22176836
6.

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.

Liu F, Zhang Y, Peng Z, Gao H, Xu L, Chen M.

J Transl Med. 2012 Jul 2;10:135. doi: 10.1186/1479-5876-10-135.

7.

Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.

Pan HZ, Dong AB, Wang L, Tan SS, Yang Q, Tong XY, Liang J, Wang JR.

Eur Rev Med Pharmacol Sci. 2013 Apr;17(8):1095-101.

8.

Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.

Zhao ZK, Yu HF, Wang DR, Dong P, Chen L, Wu WG, Ding WJ, Liu YB.

World J Gastroenterol. 2012 Dec 7;18(45):6651-6. doi: 10.3748/wjg.v18.i45.6651.

9.

MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.

Yu L, Zhang J, Guo X, Li Z, Zhang P.

Cancer Epidemiol. 2014 Aug;38(4):408-13. doi: 10.1016/j.canep.2014.05.001. Epub 2014 Jun 10.

PMID:
24923856
10.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
11.

Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.

Zhang G, Liu T, Wang Z.

J Invest Surg. 2012 Apr;25(2):93-9. doi: 10.3109/08941939.2011.606875. Epub 2011 Sep 26.

PMID:
21942217
12.

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis.

Huang Y, Li LZ, Zhang CZ, Yi C, Liu LL, Zhou X, Xie GB, Cai MY, Li Y, Yun JP.

J Transl Med. 2012 May 24;10:106. doi: 10.1186/1479-5876-10-106.

13.

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

Wang H, Jiang S, Zhang Y, Pan K, Xia J, Chen M.

World J Surg Oncol. 2014 Jul 18;12:226. doi: 10.1186/1477-7819-12-226.

14.

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Guo X, Xiong L, Yu L, Li R, Wang Z, Ren B, Dong J, Li B, Wang D.

Diagn Pathol. 2014 Sep 18;9:175. doi: 10.1186/s13000-014-0175-y.

15.

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H.

Cancer. 2012 May 1;118(9):2431-42. doi: 10.1002/cncr.26566. Epub 2011 Oct 11.

16.
17.

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.

Li M, Luo RZ, Chen JW, Cao Y, Lu JB, He JH, Wu QL, Cai MY.

J Transl Med. 2011 Jan 5;9:5. doi: 10.1186/1479-5876-9-5.

18.

Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.

Kong J, Zhou X, Liu S, Jin T, Piao Y, Liu C, Lin Z.

Int J Clin Exp Pathol. 2014 May 15;7(6):3018-27. eCollection 2014.

19.

Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.

Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP, Wang HY.

BMC Cancer. 2011 Jun 25;11:271. doi: 10.1186/1471-2407-11-271.

20.

Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.

Fang F, Luo LB, Tao YM, Wu F, Yang LY.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):409-16. doi: 10.1158/1055-9965.EPI-08-0575.

Supplemental Content

Support Center